Sunday, November 23, 2025
Digital EditionUnique new capabilities for Aspen InfoPlus.21, Aspen PIMS, and Aspen Petroleum Scheduler create additional profit opportunities for customers
The company is currently examining processes and controls at all its API manufacturing and quality units
Plagued by stagflation, the chemical industry hopes that the new government to put the economy back on growth path by fast-tracking policy initiatives
In this interview, Sameer Nagpal, MD and CEO of Shalimar Paints Ltd, shares the company's turnaround strategy and changing market dynamics of paints industry
The contract is for JBF's PTA project in Mangalore
This follows last year's breakup of the Belaruskali-Uralkali consortium
The manufacturing operations have been temporarily suspended at the plant
Instead of March, the plant will shut down from February 26 for maintenance
More than half of the investment is by firms based outside the US
The sale covers Shell's Geelong Refinery and 870-site retail business - along with its bulk fuels, bitumen, chemicals and part of its lubricants businesses in Australia
The mission, in this new phase, will make greater effort to promote application-oriented R&D
Market for bio-based materials and chemicals to become nearly 13.2 million tonne, while specialty chemicals expand six-fold to 5,90,000 MT in 2017, according to Lux Research
With this model, both companies expect to broaden reach of raltegravir in private and public markets in India
Altaf Jiwani to take over the additional responsibility of CFO
This follows the sale of Elder's domestic formulations business to Torrent Pharmaceuticals in December 2013
BASF will now focus on business with solid and powder masterbatches
This divestiture allows Ashland to focus on its core specialty chemicals business
He will also be responsible for developing Lupin's core strategy for inhalation in the developed markets
The Clean Fuels Project involves upgrading Kuwait's Mina Abdullah and Mina Al-Ahmadi refineries in order to increase capacity
The Indian pharmaceutical industry is going through a period of significant volatility and uncertainty, requiring companies to re-visit their traditional growth strategies to succeed